As product sourcing and formulations proliferate and organizations expand into new markets on a global scale, initiatives such as the Globally Harmonized System of Classification and Labeling of ...
The US Food and Drug Administration (FDA) will soon decide on whether to expand the label of MSD’s Welireg (belzutifan) to include its use for the treatment of the rare cancer pheochromocytoma and ...